Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28,862,386
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
2,150,612
-
Shares change
-
+2,067,856
-
Total reported value, excl. options
-
$53,523,700
-
Value change
-
+$51,463,341
-
Number of buys
-
35
-
Number of sells
-
-1
-
Price
-
$24.88
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2014
38 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q4 2014.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,150,612 shares
of 28,862,386 outstanding shares and own 7.5% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (622,597 shares), MORGAN STANLEY (547,534 shares), WELLS FARGO & COMPANY/MN (278,750 shares), LPL Financial LLC (103,132 shares), CREDIT SUISSE AG/ (98,299 shares), UBS Group AG (79,875 shares), FIRST TRUST ADVISORS LP (63,850 shares), OPPENHEIMER & CO INC (45,492 shares), GUGGENHEIM CAPITAL LLC (33,942 shares), and AMERICAN INTERNATIONAL GROUP INC (33,403 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.